Market scenario-
The Oxygen Therapy Equipment Market is witnessing a significant surge in demand, driven primarily by the growing prevalence of respiratory diseases and advancements in healthcare infrastructure. Market Research Future (MRFR's) latest report on the global oxygen therapy equipment market size projected to grow at a CAGR of 5.8% over the forecast period of 2023-2032. Among the various segments within this market, oxygen therapy delivery devices stand out as crucial components. These devices, including oxygen masks, nasal cannulas, and oxygen concentrators, play a pivotal role in delivering supplemental oxygen to patients with respiratory ailments. The increasing adoption of portable and user-friendly oxygen therapy delivery devices is reshaping the market landscape, catering to the needs of patients requiring oxygen therapy both in clinical settings and at home. Technological innovations, such as lightweight and compact designs, enhanced battery life, and improved oxygen delivery efficiency, are further propelling the growth of this segment.
Moreover, the rising geriatric population, coupled with the prevalence of chronic obstructive pulmonary disease (COPD) and other respiratory disorders, is fueling the demand for oxygen therapy delivery devices. Healthcare providers are increasingly recognizing the benefits of these devices in managing respiratory conditions effectively, thereby driving market expansion. Additionally, the advent of telemedicine and home healthcare services has bolstered the adoption of oxygen therapy delivery devices, enabling remote monitoring and management of patients' oxygen therapy needs. However, challenges related to reimbursement policies and stringent regulatory frameworks may pose obstacles to market growth. Nonetheless, with continuous research and development efforts aimed at improving device efficacy and patient comfort, the oxygen therapy equipment market, particularly the segment of oxygen therapy delivery devices, is poised for sustained expansion in the coming years.
Segmentation
The oxygen therapy equipment market has been segmented based on product, portability, application, and end-users.
By product, the oxygen therapy equipment market has been segmented into oxygen source equipment, oxygen delivery devices. The oxygen source equipment segment has been further segmented into oxygen concentrators, liquid oxygen devices, and oxygen cylinders. The oxygen concentrators sub-segment has been further segmented into portable oxygen concentrators and fixed oxygen concentrators. The oxygen delivery devices segment has been further segmented into bag valve masks, venturi masks, oxygen masks, non-rebreather masks, nasal cannulas, and other devices.
By portability, the oxygen therapy equipment market has been segmented into stationary oxygen therapy devices and portable oxygen therapy devices.
By application, the oxygen therapy equipment market has been segmented into cystic fibrosis, asthma, COPD, pneumonia, respiratory distress syndrome, and other diseases.
By end-user, the oxygen therapy equipment market has been segmented into home care settings, hospitals, ambulatory surgical centers & physician offices, and others.
Competitive Landscape
Messer Medical Austria GmbH, Esex Industries, Inc., Linde Healthcare (A Division of Linde Group), Allied Healthcare Products Inc., Fisher & Paykel Healthcare Corporation Limited, Medicop D.O.O, Taiyo Nippon Sanso Corporation, Teleflex Incorporated, Invacare Corporation, Becton Dickinson and Company, Smiths Medical (A Division of Smiths Group PLC), Drägerwerk AG & Co. KGaA, and Philips Healthcare (A Division of Koninklijke Philips N.V.) are the oxygen therapy equipment companies in the globe .
Regional Analysis
Region-wise, the oxygen therapy equipment market has been segmented into the Americas, the Middle East & Africa (MEA), Asia Pacific (APAC), and Europe.
The Americas is at the forefront of the global oxygen therapy equipment market. The presence of a massive patient population suffering from diseases such as COPD, pneumonia, and other respiratory disorders induce high demand for oxygen therapy equipment in the region. High healthcare expenditure in the developed economies of the region combined with favorable reimbursement policies is spurring the growth of the market. The US and Canada are the key contributors to the Americas market.
Europe is following the Americas' lead. Factors such as high government support and increasing incidence rate of respiratory devices are boosting the growth of the market.
The APAC oxygen therapy equipment market is likely to be driven by factors such as the surging prevalence of respiratory disorders, rising government support, high healthcare expenditure in the emerging economies, increased adoption rate, and improving reimbursement landscape.
The MEA market accounts for the least share of the global oxygen therapy equipment market. The majority of the market share is held by the Middle East, where a developed sector and high healthcare expenditure by the GCC countries is boosting the market growth. Concurrently, low healthcare penetration, and poor economic condition hinder the growth of the market.
Related reports-
Cardiopulmonary Resuscitation Market
For more information, Please Visit us @ Market Research Future
English
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
urdu